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Abstract:
Introduction: Community-associated methicillin resistant Staphylococcus aureus (CA-MRSA) has
emerged as the most common cause of skin and soft-tissue infections (SSTI) in the United
States. A nearly three-fold increase in SSTI visit rates had been documented in the nation’s
emergency departments (ED). The objective of this study was to determine characteristics
associated with ED performance of incision and drainage (I+D) and use of adjuvant antibiotics in
the management of skin and soft tissue infections (SSTI). Methods: Cross-sectional study of the
National Hospital Ambulatory Medical Care Survey, a nationally representative database of ED
visits from 2007-09. Demographics, rates of I+D, and adjuvant antibiotic therapy were described.
We used multivariable regression to identify factors independently associated with use of I+D
and adjuvant antibiotics.Results: An estimated 6.8 million (95% CI: 5.9-7.8) ED visits for SSTI
were derived from 1,806 sampled visits; 17% were for children <18 years of age and most visits
were in the South (49%). I+D was performed in 27% (95% CI 24-31) of visits, and was less
common in subjects <18 years compared to adults 19-49 years (p<0.001), and more common in
the South. Antibiotics were prescribed for 85% of SSTI; there was no relationship to performance
of I+D (p=0.72). MRSA-active agents were more frequently prescribed after I+D compared to nondrained lesions (70% versus 56%, p<0.001). After multivariable adjustment, I+D was associated
with presentation in the South (OR 2.36; 95% CI 1.52-3.65 compared with Northeast), followed by
West (OR 2.13; 1.31-3.45), and Midwest (OR 1.96; 1.96-3.22).Conclusion:Clinical management
of most SSTIs in the U.S. involves adjuvant antibiotics, regardless of I+D. Although not necessarily
indicated, CA-MRSA effective therapy is being used for drained SSTI. [West J Emerg Med.
2014;15(4):491–498.]
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Introduction: Community-associated methicillin resistant Staphylococcus aureus (CA-MRSA) has
emerged as the most common cause of skin and soft-tissue infections (SSTI) in the United States.
A nearly three-fold increase in SSTI visit rates had been documented in the nation’s emergency
departments (ED). The objective of this study was to determine characteristics associated with ED
performance of incision and drainage (I+D) and use of adjuvant antibiotics in the management of
skin and soft tissue infections (SSTI).
Methods: Cross-sectional study of the National Hospital Ambulatory Medical Care Survey, a
nationally representative database of ED visits from 2007-09. Demographics, rates of I+D, and
adjuvant antibiotic therapy were described. We used multivariable regression to identify factors
independently associated with use of I+D and adjuvant antibiotics.
Results: An estimated 6.8 million (95% CI: 5.9-7.8) ED visits for SSTI were derived from 1,806
sampled visits; 17% were for children <18 years of age and most visits were in the South (49%).
I+D was performed in 27% (95% CI 24-31) of visits, and was less common in subjects <18 years
compared to adults 19-49 years (p<0.001), and more common in the South. Antibiotics were
prescribed for 85% of SSTI; there was no relationship to performance of I+D (p=0.72). MRSA-active
agents were more frequently prescribed after I+D compared to non-drained lesions (70% versus
56%, p<0.001). After multivariable adjustment, I+D was associated with presentation in the South
(OR 2.36; 95% CI 1.52-3.65 compared with Northeast), followed by West (OR 2.13; 1.31-3.45), and
Midwest (OR 1.96; 1.96-3.22).
Conclusion:Clinical management of most SSTIs in the U.S. involves adjuvant antibiotics, regardless
of I+D. Although not necessarily indicated, CA-MRSA effective therapy is being used for drained
SSTI. [West J Emerg Med. 2014;15(4):491–498.]

INTRODUCTION
Background
Community-associated methicillin resistant
Staphylococcus aureus (CA-MRSA) has emerged as the most
Volume XV, NO. 4 : July 2014

common cause of skin and soft-tissue infections (SSTI) in the
United States, especially in purulent skin abscess. In many
areas of the country, MRSA prevalence is as high as 75-80%
among cultured SSTI.1–7 This epidemic has disproportionately
491
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affected patients presenting to the emergency department
(ED), where a nearly three-fold increase in SSTI visit rates
had been documented in adults and children, and increases
in both skin abscesses and cellulitis have been observed.8–10
Although the rise in SSTIs due to MRSA has led to an
increase in hospitalizations and, in some cases, invasive
disease, the majority of skin infections are managed in
ambulatory settings, including the ED.8,9
Importance
The rise in SSTIs and CA-MRSA has led to significant
changes in clinical ED practice. First, the determination of
the presence of an abscess, as opposed to a cellulitis, is an
increasingly frequent diagnostic challenge faced by emergency
physicians (EP). As a result, many EPs are using formal or
bedside ultrasonography for diagnostic evaluation of SSTI.11–13
Also, due to the increasing number of patients presenting
with purulent abscess, incision and drainage (I+D) procedures
are more frequently indicated. I+D can be especially time
consuming in children, as procedural sedation is often
required, which also carries inherent risk to the patient.14,15
Therapeutic decisions regarding use of antibiotic therapy are
also changing. Soon after the emergence of CA-MRSA, use of
agents “active” against this organism, such as clindamycin and
trimethoprim-sulfamethoxazole (TMP-SMX) has increased,
while ß-lactam antibiotics, which provide empiric therapy
for methicillin-sensitive S. aureus (MSSA) and ß-hemolytic
streptococcus (BHS) are prescribed less frequently.8,14–16 The
implications of this shift in antibiotic therapy, however, are
uncertain. Despite a growing body of evidence suggesting
that antibiotics may not be necessary for adequately drained
skin abscesses,17–19 studies have found that use of adjuvant
antibiotics is common.14,20 These various studies have reported
changes in clinical practice with respect to treatment of SSTI,
although many of these consist of single institution and survey
studies, and isolated pediatric or adult data.
Goals of this Investigation
The objective of our study was to investigate national
practice patterns of SSTI management in the ED. Specifically,
we determined national rates of I+D use and patterns of
antibiotic prescribing for ED patients with SSTIs.
METHODS
Study Design, Setting, and Subjects
We analyzed data from the National Hospital Ambulatory
Medical Care Survey (NHAMCS), a cross-sectional survey
conducted annually by the National Center for Health
Statistics (NCHS).21 The survey is used to collect information
about patient demographics, diagnoses, medications
prescribed, and procedures performed on a nationally
representative sample of ED visits in the U.S. To collect data
from a nationally representative sample of visits, the NCHS
administers the survey at participating hospitals using a fourWestern Journal of Emergency Medicine

stage probability sampling design, after sampling geographic
primary sampling units (PSUs), the NCHS samples hospitals
within PSUs, emergency service areas and in-scope
ambulatory surgery locations within hospitals, and visits
within these settings. Data from sampled visits are collected
by hospital staff, who were trained by and maintained contact
with trained field representatives during the reporting period.
The NCHS provides probability weights – equal to the
inverse probability of any visit being sampled – that allow
for the generation of nationally representative estimates
using data collected in the NHAMCS. The study was granted
exemption from the institutional review board review.
Methods and Measurements
In our analysis, we combined data collected in the
NHAMCS between 2007 and 2009. The analysis was
restricted to initial visits for an SSTI; we excluded visits
for follow up. Methodology for identification of SSTI in
NHAMCS mirrored that of previous published studies: we
identified visits for SSTI using International Classification
of Disease, Ninth Revision, Clinical Modification (ICD-9CM) codes for skin and soft issue infection (680.xx-682.
xx), which includes carbuncle, folliculitis, cellulitis, and
skin abscess.8,9,22 Although the NHAMCS allows for up to
three diagnosis codes to be assigned to a visit, we defined
SSTI based upon the primary diagnosis listed. Study
subjects included patients of all ages, and we analyzed
participants’ demographic data including race, gender,
and insurance status. Location of ED care, in terms of
geographic region, was also collected in the NHAMCS and
described in our study. Geographic regions were defined
using US Census Track Regions, including the Northeast,
South, Midwest, and West.
Details of ED visits, including performance of
drainage procedures, diagnostic testing, ED disposition,
and prescription antibiotic use were recorded at each visit.
Performance of diagnostic testing—including complete
blood count, blood culture, or wound culture–was indicated
via check box in the patient record form. We dichotomized
ED disposition as outpatient management or hospitalization,
which included admission to an inpatient ward or
observation unit. Antibiotics were categorized using the
Multum Lexicon Therapeutic Classification System. Starting
with the 2006 surveys, the NHCS began to code drugs using
the Multum system, which characterizes drugs using a threetiered hierarchy. For example, beta-lactamase inhibitors are
a “level 3” category of drugs within the “level 2” category
that includes all penicillins. Penicillins, in turn, belong to
a “level 1” category that includes all anti-infectives. In
addition to broad categories, the Multum system allows
for identification of specific drugs (e.g., clindamycin).
For the purposes of our analysis, we grouped antibiotics
into the following categories: anti-MRSA (trimethoprimsulfamethoxazole, clindamycin, daptomycin, tetracyclines,
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Table 1. Characteristics of initial emergency department (ED) visits for skin and soft tissue infections (SSTI) among study patients*†
Estimated survey
weighted ED visits
(in millions)

All SSTI††
(n=1,806)

No I+D††
(n=1,311)

I+D††
(n=495)

2007

2.03

30%

31%

27%

2008

2.47

36%

35%

39%

2009

2.32

34%

34%

34%

<18

1.16

17%

18%

15%

18-49

3.89

57%

53%

69%

>49

1.77

26%

29%

16%

White

4.84

71%

77%

57%

Nonwhite

1.98

29%

23%

43%

Male

3.48

51%

50%

52%

Female

3.34

49%

50%

48%

Private

4.57

67%

67%

70%

Public/other

2.25

33%

33%

30%

Northeast

1.09

16%

19%

9%

Midwest

1.09

16%

17%

16%

South

3.34

49%

45%

58%

1.30

19%

19%

18%

p-value
(X2)

Year
0.51

Age (years)
<0.0001

Race
<0.0001

Gender
0.64

Insurance status
0.23

US census track region

West

<0.001

*Survey weights applied; Totals may be >100%; Proportions represent total within each column; I+D, incision and drainage.
†

††

vancomycin, linezolid, and tigecycline), β-lactam (penicllins,
cephalosporins, and carbapenems), and other (rifampin,
macrolides, aminoglycosides, and quinolones).
Statistical Analysis
All statistical analyses took into account the complex
sampling design of the NHAMCS, including sample weights,
stratification, and clustering variables. Description of study
subjects and ED visits were made using standard descriptive
statistics. We made univariate comparisons using the χ2-test
for proportions, and p-values were reported with a significance
level of <0.05. Specifically, we compared patient characteristics,
diagnostic testing, and adjuvant antibiotic prescription between
patients with and without an incision and drainage procedure
performed. To identify independent patient characteristics
associated with clinical care of SSTI and to account for
potential confounding, we performed multivariable logistic
regression. Two regression models were created: one to identify
factors independently associated with performance of I+D,
and a second to assess factors associated with prescribing
Volume XV, NO. 4 : July 2014

of adjuvant antibiotics among subjects that had a drainage
procedure. We reported values as adjusted odds ratios (OR) with
95% confidence intervals (CI). We conducted all analyses using
STATA 11 software (Stata Corp, College Station, TX).
RESULTS
Characteristics of Study Subjects
During the study period, based on a sample of 1,806
actual visits in the NHAMCS database, there were an
estimated 6.82 (95% CI: 5.88-7.75) million initial ED visits
for SSTI in the U.S. This corresponds to an average of 2.27
million visits annually. Survey weighted demographics of the
study population are presented in Table 1. Most study subjects
were above the age of 18 years, Caucasian, and privately
insured. The largest number of SSTIs occurred among patients
in the 18-49 year age group, while children (<18 years) had
the fewest. The rate of ED visitation for SSTI was highest in
the southern U.S., compared to other regions (Table 1).
Emergency Department Clinical Care for SSTI
Among visits for SSTI, an estimated 27% (95% CI:
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other than the U.S. Northeast, with the strongest association
observed in the South. Among patients undergoing I+D,
adjuvant antibiotic therapy was only associated with patients
treated in the South (OR 3.23; 1.41-7.40 compared with the
Northeast) (Table 3).

Table 2. Antibiotics prescribed for study subjects.
Variable

Overall

No I+D

I+D

p-valuee

Any antibiotic usea

85%

85%

84%

0.72

Anti-MRSA monotherapyb

43%

38%

57%

<0.0001

β-lactam monotherapyc

23%

27%

13%

<0.0001

Anti-MRSA + β-lactam
combination

15%

16%

11%

0.08

4%

5%

3%

0.18

15%

15%

16%

0.72

Other antibioticsd
No antibiotics

Values may not sum accurately as a result of rounding
Includes sulfonamides, tetracyclines, clindamycin, vancomycin,
linezolid, daptomycin, and tigecyclin.
c
Includes cephalosporins, penicillins, and carbapenems.
d
Includes macrolides, aminoglycosides, quinolones, and rifampin.
e
Chi-square comparisons of No I+D with I+D
I+D, incision and drainage
a
b

24-31) had an I+D procedure performed. Performance of
I+D occurred more often in patients who were 18-49 years
of age (p<0.001), non-white, and when treated in the South
(p<0.001). Wound cultures were performed in 16% of visits
for SSTI, and they were performed more frequently when I+D
was also performed (31%) than when I+D was not performed
(11%) (p<0.001). Among the study population, ancillary
diagnostic testing was obtained in many patients: 27% had a
complete blood count and 12% had a blood culture obtained in
the ED; each were more likely to be obtained in patients when
an I+D was not performed (p<0.001). The majority of patients
were cared for as outpatients, with only 15% of study subjects
hospitalized after the ED visit. Hospitalization for SSTI was
less common when I+D was performed during the ED visit
(5%) than when I+D was not performed (19%) (p<0.001).
Overall, 85% of patients with SSTI received an antibiotic
prescription. There was no difference in the rate of antibiotic
use between those who did or did not receive an I+D (84%
versus 85%, p=0.72). However, there were significant
differences in antibiotic choices based on whether an I+D
was performed. The majority (70%) of patients who had
I+D were prescribed an anti-MRSA antibiotic, compared
to 56% of those not receiving I+D (p<0.0001) (Table 2).
Combination therapy, with prescription of anti-MRSA and
beta-lactam antibiotics, was used in 15% of subjects; there
was no association between the use of combination therapy
and performance of a drainage procedure (p=0.08).
Multivariable Analysis
After adjusting for other potentially confounding factors,
performance of I+D was significantly associated with patient
age of 18-49 years, non-white race, and care in regions
Western Journal of Emergency Medicine

DISCUSSION
This study provides a nationally representative overview
of ED management for patients with SSTIs. While I+D
is considered the mainstay of therapy for purulent SSTI,
it is performed in less than half of children presenting to
the ED for an SSTI. Overall drainage procedure are less
commonly performed for children <18 years compared to
adults 18-48 years of age, and more commonly performed
in non-white patients, and in those presenting outside of the
Northeast. Furthermore, adjuvant antibiotic use for SSTIs is
commonplace, regardless of whether or not I+D is performed.
Though the majority of subjects are receiving CA-MRSA
active therapy, consistent with current epidemiology, current
evidence indicates that antibiotic therapy may be unnecessary
for purulent abscesses that are adequately drained.
I+D remains the mainstay of treatment for purulent skin
abscesses, irrespective of patient characteristics or site of
care.16,23,24 However, the results of our study demonstrate that
for SSTIs presenting to the ED, I+D appears to be less likely to
be performed in pediatric patients and white patients. While the
ED is often the preferred site of care for potentially drainable
SSTI, the pediatric population is less likely to receive an I+D.
It is possible, though unlikely, that the prevalence of cellulitis
is higher than abscess in the pediatric population; current
administrative databases do not permit discrimination between
ICD-9 codes for these infections. Factors such as reluctance
to perform an empiric I+D procedure because of incurred pain
or need for procedural sedation, or the limited use of bedside
ultrasonography in children, may explain this finding, in part.
For example, sedation possesses inherent logistical challenges
in the ED setting, such as time required and associated risks; in
addition, sedation is more likely to be employed in academic
settings, which is not representative of the majority of ED
visits across the U.S.15 In addition, bedside ultrasonography
is underused in pediatric patients,25,26 though it has proven
benefit in adults; abscesses are often underdiagnosed compared
with examination, and therefore may not receive I+D.12,27
With respect to patient race and performance of I+D, there
is suggestion that CA-MRSA and SSTI are more common in
blacks, as compared to other races,28–31 which accounts for
differences in the performance of I+D; CA-MRSA infection is
related to increased risk of abscess formation, and mirrors this
epidemiologically.2,6,29
Several geographic differences with respect to SSTI
management were elicited in our study, even after adjustment
for multiple patient factors, including age, race, and insurance
status. Patients with SSTI treated in EDs outside of the
Northeast underwent I+D more frequently: compared with the
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Table 3. Multivariable regression analyses of factors associated with performance of incision and drainage and with receipt of adjuvant
antibiotics coupled with incision and drainage in patients with skin and soft-tissue infections.
% Receiving I+D

AOR (95% CI)

% Receiving antibiotics

AOR (95% CI)

2007

25%

1.00

91%

1.00

2008

29%

1.30 (0.90-1.90)

80%

0.57 (0.25-1.29)

2009

27%

1.34 (0.96-1.87)

83%

0.49 (0.23-1.04)

Year

Age
<18

24%

1.00

87%

1.00

18-49

32%

1.77 (1.23-2.55)

84%

0.46 (0.12-1.70)

>49

17%

0.94 (0.60-1.49)

81%

0.42 (0.10-1.66)

White

22%

1.00

85%

1.00

Nonwhite

41%

2.34 (1.71-3.19)

83%

0.77 (0.43-1.40)

Male

28%

1.00

85%

1.00

Female

26%

0.86 (0.63-1.18)

83%

1.09 (0.58-2.03)

Private

25%

0.96 (0.74-1.25)

84%

0.92 (0.47-1.80)

Public/other

28%

1.00

85%

1.00

Race

Sex

Insurance status

US census region
Northeast

15%

1.00

72%

1.00

Midwest

26%

1.96 (1.19-3.22)

78%

1.90 (0.62-5.81)

South

32%

2.36 (1.52-3.65)

89%

3.23 (1.41-7.40)

West

26%

2.13 (1.31-3.45)

78%

1.31 (0.49-3.52)

I+D, incision and drainage; AOR, Adjusted Odds Ratio

Northeast, patients treated in the South were twice as likely
to have an I+D performed and three times as likely to receive
adjuvant antibiotics after the I+D. However, it is unclear
whether a true association exists between region and treatment
strategies. It should be noted that the prevalence of CA-MRSA
is highest in urban centers located in the South (Atlanta,
Houston, Dallas), in the Midwest (Chicago, St. Louis), and
in the West (San Francisco, Los Angeles), with rates as high
80-85% in many of these locations.1,3,6,7,19,29,30 Meanwhile,
many centers in the Northeast (New York, Philadelphia)
documented rates of MRSA less than 70%.29,32 Nonetheless,
while the incidence of skin abscesses is related to CAMRSA prevalence, it is unclear if this regional relationship
purely reflects ED visitation, population demographic, or
actual differences in clinical care. These findings should be
interpreted in light of the fact that our ability to identify skin
abscess was based on best literature-supported methods for
administrative data; the true clinical scenario of abscess versus
cellulitis cannot be assessed, and the prevalence of CA-MRSA
in cellulitis is not known.
Our study confirms the frequent use of systemic antibiotics
Volume XV, NO. 4 : July 2014

for SSTIs managed in the ED, which was not influenced by
the performance of I+D: approximately 85% of all patients
received adjuvant antibiotic therapy. This finding has important
implications. For some patients, especially children among
whom barriers to performing drainage exist, ED physicians
may be using antibiotic therapy instead of performing a
drainage procedure. It cannot be overemphasized that adjuvant
antibiotics are not a substitute for I+D when treating purulent
skin abscesses, and the assumption that antibiotic therapy
alone will adequately treat a skin abscess might increase
the possibility of treatment failure. Moreover, this high rate
of adjuvant antibiotic use suggests that ED physicians are
reluctant to withhold antibiotic therapy, despite recent evidence
demonstrating a general lack of efficacy of this practice.18,19
However, recent evidence suggests that I+D alone is sufficient
for most ED patients with uncomplicated abscess. Chen et al
demonstrated that failure rates between pediatric skin abscesses,
in a study population with 70% CA-MRSA, did not differ when
treated with adjuvant clindamycin compared to the non-MRSA
active cephalexin (3 versus 6%, p=0.50).17 The most salient of
these was a methodologically sound, non-inferiority study of
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TMP-SMX versus placebo in drained skin abscess, by Duong
et al in 2010. Treatment failure in the placebo group was 5.3%,
compared with 4.1% in the TMP-SMX group (mean difference
1.2% 95% CI: -∞ to 6.8).19 These results, in conjunction with
current evidence and national guideline recommendations,
strongly suggest that adjuvant antibiotic therapy does not
or only minimally improves cure rates compared with
placebo or use of an agent that was inactive against the
pathogen.1,3,18,19,24,24,33 These findings support the need for
knowledge dissemination of these studies and guideline
recommendations, continued surveillance of ED prescribing
practices, and more judicious use of adjuvant therapy.
On the other hand, our findings suggest that EPs do
appear to be tailoring their antibiotic selection patterns based
on the epidemiology of the infection. Use of anti-MRSA
therapy, including clindamycin and TMP-SMX, was higher
for patient visits where I+D was performed. This is consistent
with the likely differences in pathogens between purulent
and nonpurulent SSTI: purulent SSTI such as abscesses are
more likely to be caused by S. aureus, whereas nonpurulent
cellulitis and erysipelas are more likely to be caused by
BHS.29,34,35 Therefore, if antibiotics are deemed necessary
for the management of purulent SSTI, an antibiotic with
activity against MRSA is generally recommended, typically
clindamycin or TMP-SMX, based on local resistance
patterns.16,24 With respect to non-purulent SSTI, a recent study
of inpatients residing in a high-MRSA prevalence community
demonstrated that BHS was the causative agent in 73% of
cases of non-purulent cellulitis.34 Therefore, use of therapy with
activity against BHS for cellulitis, especially beta-lactams or
clindamycin is prudent, as TMP-SMX alone is not considered
adequate and has been associated with treatment failure when
used as monotherapy for non-drained SSTIs.10
Differences exist with respect to ancillary testing and
ED disposition for SSTIs, based on performance of I+D. In
the setting of a known abscess, clinicians will be more likely
to perform drainage without additional testing. Diagnosis
of and treatment of skin abscess is more straightforward as
compared to non-drained lesions, where cellulitis, or even
deeper skin lesions may be a consideration. As a result, it
is logical that patients with non-drained SSTI were more
likely to receive laboratory testing, including complete blood
counts and blood cultures. While there may be an effect from
institutional differences, these findings seem justified, as
patients with non-drained SSTIs were also four-times as likely
to be admitted to the hospital for continued therapy. Although
many physicians continue to favor use of serum testing in
SSTI management.14 It should be noted that serum testing adds
little to the management of SSTI, and rates of bacteremia in
cellulitis and skin abscess remain quite low.36 Notably, wound
cultures were not obtained in the majority of SSTI even after
drainage. This is incongruent with current recommendations
from the IDSA and CDC, which recommend wound culture in
the management of SSTI to monitor for therapeutic failure, and
Western Journal of Emergency Medicine

track current S. aureus epidemiolgy.16,24
LIMITATIONS
Among the limitations to our findings is the use of
large-scale administrative data from NHAMCS, as has
been well documented.37 Specifically, the NHAMCS
survey does not include some potentially important clinical
information that could influence treatment decisions
around I+D or antibiotic use, including lesion size or prior
history of MRSA or SSTI. As a result, we are not able to
fully evaluate the appropriateness of clinical management.
NHAMCS is also limited by its use of ICD-9 codes for
diagnosis. In the case of SSTI, ICD-9 does not distinguish
between cellulitis and abscess, and use of ICD-9 codes for
SSTI and procedure codes of I+D to identify abscesses is
limited and prone to misclassification. Additionally, the
limited sample of patients did not permit sub-analysis of
our study population by smaller increments of age, and it
is possible that further differences exist in management of
younger pediatric patients compared to older adolescents.
In addition, regional differences found in our study may
not be accurate, as NHAMCS coding and Census Track
Regions results in overrepresentation of the South in
terms of ED visits. Since our data source did not contain
results or microbiologic testing for ED patients with
SSTI, we could not confirm this relationship between CAMRSA prevalence and the need for incision and drainage.
Although relatively unlikely, particularly because we
restricted our analysis to initial ED visits, some patients
may have undergone I+D previously in an office setting,
which would not have been captured by the NHAMCS
dataset. Finally, although we found differences in clinical
care across the large geographic areas of U.S. Census Track
Region, we could not comment on actual care provided, or
account for potentially important differences across smaller
geographic areas.
CONCLUSION
In spite of current literature disputing the need for
adjuvant antibiotic therapy for uncomplicated SSTI that
has undergone I+D, this practice remains common in adults
and children presenting to the ED for skin abscesses. While
CA-MRSA active therapy for drained SSTI has increased
concomitant with the rise in CA-MRSA, prescribing practices
for non-drained SSTIs such as cellulitis reflect increased use
of CA-MRSA active therapy, which may not be appropriate,
as Group A Streptococcus remains prevalent. Meanwhile,
the practice of serum testing for non-drained SSTI remains
common, despite uncertainty in the diagnostic and therapeutic
utility. Nationally representative studies are essential
for evaluating current practice for SSTI, and continued
assessments of antibiotic therapy will be necessary to evaluate
dissemination of evidence regarding appropriate use of
diagnostics and adjuvant antibiotics for SSTIs.
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